Buckingham Research Upgrades Salix Pharmaceuticals (SLXP) to Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. APLD
7. ORCL
8. USO
9. STZ
10. AAPL

Go back to Buckingham Research Upgrades Salix Pharmaceuticals (SLXP) to Buy

Progenics (PGNX), Salix (SLXP) Surge on FDA AdCom Review for RELISTOR

June 11, 2013 11:23 AM EDT

Shares of Progenics Pharmaceuticals (NASDAQ: PGNX) are surging 26% mid-day after the company and partner Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) announced that the FDA is seeking input from an Advisory Committee on Salix's Supplemental New Drug Application (sNDA) for RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection, for opioid-induced constipation, or OIC, in patients with chronic pain.

The FDA's action to convene an Advisory Committee was taken in response to the formal appeal by Salix of the complete response action taken by the FDA on July 27, 2012 regarding... More